drugset / Trial / NCT02253524

Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo

NCT02253524

Phase 4 Completed 200 enrolled Pamukkale University
RandomizedFactorialTriple-blindTreatment

Summary

* Vertigo complaint is one of the common cause of patients who applied to emergency services. * Patients who have applied to emergency services with vertigo complaint mostly have nausea as an additionally symptom to this complaint and anti-emetic agents can be used in their treatments very often. * The investigators purpose is to investigate the advantages of Dimenhydrinate and metoclopramide to each other in the treatment of vertigo and the vertigo accompanied by nausea

Timeline

Start
2012-11
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dimenhydrinate Small molecule 50 mg Intravenous
Comparator Metoclopramide Small molecule 10 mg Intravenous

Indications

No indication recorded.